Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 4.18% is 90% above its 5-year average of 2.20%, near the low end of its 5-year range (0.76%–13.75%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.38% below its 12-month average of 5.39%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.18%.
DEBT TO ASSETS RATIO
4.18%
DEBT TO ASSETS RATIO AVG TTM
5.39%
DEBT TO ASSETS RATIO AVG 3Y
2.70%
DEBT TO ASSETS RATIO AVG 5Y
2.20%
DEBT TO ASSETS RATIO AVG 10Y
1.92%
DEBT TO ASSETS RATIO AVG 15Y
2.89%
DEBT TO ASSETS RATIO AVG 20Y
2.18%
CURRENT VS TTM AVG
-22.38%
CURRENT VS 3Y AVG
+54.54%
CURRENT VS 5Y AVG
+90.20%
CURRENT VS 10Y AVG
+117.44%
CURRENT VS 15Y AVG
+44.64%
CURRENT VS 20Y AVG
+92.03%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+4544.62%
vs the sector median at left
Cellectar Biosciences, Inc.
Market Cap
$12.46M
Debt to Assets Ratio
4.18%
TTM Avg
5.39%
3Y Avg
2.70%
5Y Avg
2.20%
Market Cap
$12.57M
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.60M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.66M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.35M
Debt to Assets Ratio
0.78%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.28M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.18M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | $12.46M | 4.18% | 5.39% | 2.70% | 2.20% |
| Dare Bioscience, Inc. (DARE)vs › | $12.57M | 0.30% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.60M | 0.01% | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.66M | 0.69% | N/A | N/A | N/A |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.35M | 0.78% | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $12.28M | 0.00% | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.19M | 0.15% | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.18M | 0.05% | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.33M | 0.10% | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG)vs › | $13.40M | 0.00% | N/A | N/A | N/A |
Debt/Assets
4.2%
Debt/Equity
0.05
Current Ratio
6.66
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 4.18% |
| 2026-03-31 | 13.75% |
| 2025-12-31 | 2.73% |
| 2025-09-30 | 2.95% |
| 2025-06-30 | 3.31% |
| 2025-03-31 | 2.96% |
| 2024-12-31 | 1.94% |
| 2024-09-30 | 1.37% |
| 2024-06-30 | 1.81% |
| 2024-03-31 | 1.28% |
| 2023-12-31 | 4.58% |
| 2023-09-30 | 2.64% |
| 2023-06-30 | 8.98% |
| 2023-03-31 | 4.04% |
| 2022-12-31 | 2.80% |
| 2022-09-30 | 1.05% |
| 2022-06-30 | 0.91% |
| 2022-03-31 | 0.84% |
| 2021-12-31 | 0.81% |
| 2021-09-30 | 0.79% |
| 2021-06-30 | 0.76% |
| 2021-03-31 | 0.71% |
| 2020-12-31 | 0.72% |
| 2020-09-30 | 3.06% |
| 2020-06-30 | 2.77% |
| 2020-03-31 | 5.78% |
| 2019-12-31 | 4.31% |
| 2019-09-30 | 3.53% |
| 2019-06-30 | 3.01% |
| 2019-03-31 | 4.78% |
| 2018-12-31 | 0.01% |
| 2018-09-30 | 0.02% |
| 2018-06-30 | 0.05% |
| 2018-03-31 | 0.05% |
| 2017-12-31 | 0.04% |
| 2017-09-30 | 0.06% |
| 2017-06-30 | 0.05% |
| 2017-03-31 | 0.05% |
| 2016-12-31 | 0.62% |
| 2016-09-30 | 1.68% |
| 2016-06-30 | 1.92% |
| 2016-03-31 | 5.02% |
| 2015-12-31 | 4.48% |
| 2015-09-30 | 6.21% |
| 2015-06-30 | 5.38% |
| 2015-03-31 | 4.23% |
| 2014-12-31 | 3.45% |
| 2014-09-30 | 2.95% |
| 2014-06-30 | 72.13% |
| 2014-03-31 | 52.44% |
| 2013-12-31 | 6.63% |
| 2013-09-30 | 4.69% |
| 2013-06-30 | 3.74% |
| 2013-03-31 | 3.17% |
| 2012-12-31 | 3.96% |
| 2012-09-30 | 4.38% |
| 2012-06-30 | 3.84% |
| 2012-03-31 | 5.27% |
| 2011-12-31 | 4.32% |
| 2011-09-30 | 6.53% |
| 2011-06-30 | 5.42% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 156.68% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 24.69% |
| 2005-03-31 | 99947.27% |
